Voices from ENDA Santé and ARASA Partners

Posted by ARASA on July 15, 2016

Voices from ENDA Santé and ARASA Partners

Kedir Kedir.jpg

I am the head of Mycobacteriology Research center at Jimma University in Jimma, Ethiopia. I have been working on TB and TB/HIV operational research for the last five years, specializing in drug-resistant TB.  I would like to share the successes and challenges we face in our research work in Ethiopia with scientists, as well as communities, patient’s advocates and health care workers attending the TB 2016 conference. In addition, our research center has plans to expand the scope of research, training and advanced services in TB through the introduction of new technologies. We hope to do so in collaboration with other researches centers and researchers in other countries that are developing key tools in the TB response.  Therefore, by attending TB 2016 conference I will be able to share with scientists, researchers and organizations our work and to establish networks and to discuss opportunities for collaboration attending the conference.

I feel the TB 2016 conference will help my work because it will be addressing the current status of TB management and challenges from case recruitment, diagnosis, treatment, control and prevention point of views both in industrialized and developing countries. The conference will also deal with the patterns of burden of TB in general and in specific WHO geographical distribution.

It is important for my work to understand the latest research on the issue of drug resistance TB from diagnosis, treatment, control and prevention of views. I look forward to learning more about the discrepancy between rate of presumptive cases that get diagnosed and those not yet reached. By engaging in these discussions, I will have a better understanding of what the possibilities are of having simple point of care diagnosis tools. To establish what needs to be in place to get greater government commitment to address all patients as well as all citizens’ human rights to ensure that they benefit from a country’s health care service.

In addition, by attending the conference I will be able to engage with the advancement of both operational and basic science research in TB. The programme provides an opportunity to discuss the progress of research in line with those factors that aggravate TB like HIV/AIDS and drug resistance. I hope to benefit from engaging with new innovations (drugs, diagnostic tool and vaccines), community awareness, community engagement in TB management program and social and societal factors etc point of views will be addressed.  I hope to share what I learn in this area with my colleagues in Ethiopia and to see what future research our Centre could be engaging in.

Last but not least, the conference will enable me to engage with the current status of TB elimination programs and challenges. It will give me and my team and opportunity to be part of the call for collaboration to achieve TB elimination goals.

For me attending this international conference is a great opportunity for acquiring advanced knowledge, skills and attitudes in the TB management and research, as well as identifying best practices. Furthermore, it is also great chance for the center I am leading to establish links with other researchers and centers to discuss opportunities for collaboration.